Scientists at Northwestern University's Simpson Querrey Institute for BioNanotechnology have invented a bioactive material to successfully regenerate cartilage in the knee joints of.
Servier Pharmaceuticals, the US arm of a French pharmaceutical company, got approval from the US drug regulator for a once-daily pill to treat.
Daiichi Sankyo will pay Merck & Co. Inc., $170 million upfront to bag commercialization and development rights of the latter’s test drug for.
A family of antimicrobial compounds can neutralise necrotising fasciitis, a deadly bacterial skin infection that is also known as flesh-eating disease, when tested.
HQ Team August 6, 2024: A new cardiovascular disease risk calculator may render 16 million US citizens ineligible for preventive therapy if the.
Contineum Therapeutics, Inc., a US San Diego-headquartered biopharmaceutical company’s trial drug may reverse multiple sclerosis damage by potentially restoring movement and function.
Caristo Diagnostics, founded by four Oxford University cardiologists, has developed an AI-assisted software that can detect cardiac events a decade in advance.
Flexible, gel-like synthetic tubes can replace human veins during heart bypass operations to reroute blood flow, according to engineers at the University of.
Researchers have added two additional risk factors — untreated vision loss and high LDL cholesterol — to 12 other steps to identify dementia,.
Seventeen types of cancer are common in US millennials and the incidence rate for some forms is two to three times higher in.
